Why we need a modern act to prevent harm from medications

In The News | Apr 06, 2022

Tabula Rasa’s Jacques Turgeon, BPharm, PhD, Chief Scientific Officer and CEO, TRHC Precision Pharmacotherapy Research and Development Institute is featured in The Hill. Turgeon discusses how uncoordinated prescription regimens can lead to decreases in drug efficacy and greater risk of adverse effects, such as falls, emergency room visits, hospitalization, and even death.

Share this:

About the Author

Jessica Roe

Fill 1 Copy 2closeFill 5 Copy 4green-arrowhamburgerFill 7 Copy 4Fill 1 Copy 4pauseplaysearch-iconFill 3 Copy 4